|1.||Sowa, Grzegorz: 2 articles (11/2014 - 05/2003)|
|2.||Ohno, S: 2 articles (08/2013 - 08/2004)|
|3.||Liu, Yun-hui: 2 articles (09/2012 - 09/2010)|
|4.||Xue, Yi-xue: 2 articles (09/2012 - 09/2010)|
|5.||Koo, Ja Seung: 2 articles (01/2012 - 08/2011)|
|6.||Lisanti, Michael P: 2 articles (07/2011 - 07/2003)|
|7.||Moreno-Aliaga, M J: 2 articles (07/2005 - 05/2004)|
|8.||Milagro, F I: 2 articles (07/2005 - 05/2004)|
|9.||De Miguel, C: 2 articles (07/2005 - 05/2004)|
|10.||Cho, Wang Sik: 1 article (12/2015)|
|1.||Open-Angle Glaucoma (Glaucoma, Open Angle)
02/01/2014 - "The CAV1/CAV2 (caveolin 1 and caveolin 2) genomic region previously was associated with primary open-angle glaucoma (POAG), although replication among independent studies has been variable. "
08/01/2013 - "The caveolin 1 to caveolin 2 (CAV1-CAV2) gene region on chromosome 7q31 has been reported to be associated with susceptibility to primary open angle glaucoma (POAG) and normal tension glaucoma (NTG) in previous studies. "
11/15/2014 - "Host deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesis."
05/01/2001 - "Expression of caveolin-2 was undetectable in all of the normal colonic glands, adenomas, and carcinomas. "
07/01/2003 - "Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation."
05/01/2004 - "Caveolin-1 mRNA expression was evident in all colon carcinoma cell lines tested; however, caveolin-2 mRNA was found only in HT-29 and HCT-116. "
06/19/2003 - "Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells."
|3.||Breast Neoplasms (Breast Cancer)
07/01/2008 - "Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis."
08/15/2011 - "Our findings suggest that MiR-199a-3p targeting of caveolin-2 might have an important role in breast cancer tumor progression, making it a potential candidate for intervention in cancer."
01/01/2015 - "Finally, both syndecan-2 and caveolin-2 were upregulated in tissue arrays from breast cancer patients compared to normal mammary tissue. "
01/01/2015 - "Immunohistochemistry for syndecan-2 and its interacting partner, caveolin-2 was performed on human breast tumor tissue arrays. "
07/22/2008 - "Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype."
01/01/2011 - "The goal of this study was to investigate the expression and regulation of caveolin 1 (CAV-1) and caveolin 2 (CAV-2) in normal and glaucoma trabecular meshwork (TM) cells. "
09/01/2014 - "A single nucleotide polymorphism (SNP) identified between caveolin-1 (CAV1) and caveolin-2 (CAV2) on chromosome 7 is associated with glaucoma. "
11/01/2015 - "Importantly, our study showed for the first time that BMDMs expressed only caveolin-2, and its level decreased after activation of macrophages with LPS, IFN-γ, and/or hypoxia. "
11/01/2015 - "The expression of caveolin-2 negatively correlates with the iNOS and HIF-1α protein levels, as well as with the LPS/IFN-γ- and hypoxia-induced activation of ERK1/2. We concluded that caveolin-2 is most probably involved in regulation of pro-inflammatory responses of BMDMs, triggered via activation of ERK1/2. "
11/01/2015 - "Bone marrow-derived macrophages exclusively expressed caveolin-2: The role of inflammatory activators and hypoxia."
03/01/2009 - "Hypoxia also caused a remarkable release of type I cell markers (caveolin-2 and receptor for advanced glycation end products) in lung lavage that was almost completely abolished by WHPC. "
|2.||Proteins (Proteins, Gene)
|6.||Factor IX (PTC)
|7.||papillary Thyroid cancer
|8.||Complementary DNA (cDNA)
|9.||Messenger RNA (mRNA)